CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Proceeds from Life Insurance Policy
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Proceeds from Life Insurance Policy of $9.50 million for the 3-month period ending 2011-06-25, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLifeInsurancePolicies · last filed 2011-11-02
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from life insurance policy for the quarter ending 2011-06-25 was $9.50M.
| Period end | Proceeds from Life Insurance Policy 3 month |
|---|---|
| 2011-06-25 | $9.50M 10-Q · filed 2011-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |